z-logo
open-access-imgOpen Access
Topical issues of the efficiency and safety of using the first direct thrombin inhibitor in real clinical practice
Author(s) -
А.В. Фонякин
Publication year - 2015
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 9
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2015-4-116-120
Subject(s) - dabigatran , medicine , warfarin , atrial fibrillation , direct thrombin inhibitor , stroke (engine) , renal function , myocardial infarction , clinical practice , rivaroxaban , intensive care medicine , anesthesia , cardiology , physical therapy , mechanical engineering , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here